PMCID: PMC6281147 T Bollinger, A Bollinger, L Skrum, S Dimitrov, T Lange, W Solbach Clin Exp Immunol
Important Caveats About the Research Several important limitations should be acknowledged when reviewing the EpitalON literature: The majority of published studies originate from Khavinson's research group or closely affiliated laboratories Independent replication outside Russia has been limited, though the 2025 Biogerontology study represents a notable exception Human clinical data remains sparse, consisting mainly of small studies from one research group Most research has used injectable EpitalON, not oral formulations The peptide is not approved as a medicine in the UK, EU, or US How EpitalON Capsules Are Typically Taken Research Protocol Context The research literature commonly references cycles of 10-20 days at 5-10mg daily, repeated periodically (such as once or twice yearly)
The International Society of Dermatology
If youve been struggling with unexplained headaches along with fatigue, tingling, or mood changes, a simple blood test can help determine if B12 deficiency is the cause